[1]
NEENA KATOCH et al. 2019. TO COMPARE THE EFFICACY AND SAFETY OF RAMIPRIL VERSUS LOSARTAN IN POST-MYOCARDIAL INFARCTION PATIENTS. Asian Journal of Pharmaceutical and Clinical Research. 12, 6 (Jun. 2019), 115–118. DOI:https://doi.org/10.22159/ajpcr.2019.v12i6.32227.